TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06655103

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational movie
Description: There are three groups in this research. The 1st group will be shown an educational movie about intrathecal chemotherapy treatment before intrathecal chemotherapy treatment, the 2nd group will be shown a cartoon movie before intrathecal chemotherapy treatment, and the 3rd group will not receive any intervention before intrathecal chemotherapy treatment. In all groups, measurements will be made in parallel; fear and pain scales as well as electrodermal activity, pulse, respiration and O2 saturation values 30 minutes before IT chemotherapy treatment, in the second measurement; In the second measurement, electrodermal activity, pulse, respiration and O2 saturation values along with fear and pain scales 15 minutes before IT chemotherapy, and in the third measurement, electrodermal activity, pulse, respiration and O2 saturation values along with fear and pain scales will be evaluated within 30-60 minutes after IT chemotherapy treatment (when the sedation effect is over).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational movie
Description: There are three groups in this research. The 1st group will be shown an educational movie about intrathecal chemotherapy treatment before intrathecal chemotherapy treatment, the 2nd group will be shown a cartoon movie before intrathecal chemotherapy treatment, and the 3rd group will not receive any intervention before intrathecal chemotherapy treatment. In all groups, measurements will be made in parallel; fear and pain scales as well as electrodermal activity, pulse, respiration and O2 saturation values 30 minutes before IT chemotherapy treatment, in the second measurement; In the second measurement, electrodermal activity, pulse, respiration and O2 saturation values along with fear and pain scales 15 minutes before IT chemotherapy, and in the third measurement, electrodermal activity, pulse, respiration and O2 saturation values along with fear and pain scales will be evaluated within 30-60 minutes after IT chemotherapy treatment (when the sedation effect is over).
Study: NCT06654518

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Preoperative CBCT for Bone Density and Ridge Width Measurement
Description: Participants in this arm underwent preoperative Cone Beam Computed Tomography (CBCT) scanning to evaluate bone density and alveolar ridge width. The CBCT scans provide high-resolution, 3D images, which was used to guide the planning and placement of dental implants. The primary goal of the intervention was to assess how well the measurements obtained from CBCT could predict the primary stability of the implants postoperatively.
Study: NCT06596421

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: abdominal massage
Description: abdominal massage
Study: NCT06603870

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: Apixaban is Health Canada approved for routine treatment and secondary prevention of VTE. Upon enrollment and during follow-up, patients will be managed with a prophylactic dose of apixaban (2.5 mg orally twice daily) as long as either a CVC or active cancer is present. Apixaban will be stopped at the time of CVC removal and when cancer is in remission. Patients will be instructed to contact the study team when their CVC is removed (to determine if apixaban should be continued, based on cancer status at the time), or any thrombotic or bleeding concerns were to occur in between visits. The investigators will record loss to follow-up, drop out, or death during the study.
Study: NCT06587958

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fermented plant-based foods
Description: Participants will daily consume five different types of fermented plant-based foods, in addition to their habitual diet.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Non-fermented plant-based foods
Description: Participants will daily consume five different types of non-fermented plant-based foods, in addition to their habitual diet.

Intervention type: OTHER
Group type: OTHER
Intervention: Habitual diet
Description: Participants will follow their habitual diet.
Study: NCT06595641

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transfer Energy Capacitive Resistive Therapy
Description: It's a physical treatment modality commonly used to treat musculoskeletal pain. It normally uses a longwave radiofrequency of \~0.5 MHz. The system consists of a neutral plate and two different electrodes that can transfer energy in two modalities: capacitive and resistive

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: strength training program
Description: Each session includes five exercises, each performed for three sets of 10 repetitions:~Shoulder Retraction - Strengthens muscles between shoulder blades. Shoulder Scaption - Improves stability and range of motion. Shoulder External Rotation from Side Lying - Targets rotator cuff muscles. Shoulder Protraction - Enhances shoulder blade function. Shoulder Extension - Strengthens posterior shoulder muscles

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: strength training program
Description: Each session includes five exercises, each performed for three sets of 10 repetitions:~Shoulder Retraction - Strengthens muscles between shoulder blades. Shoulder Scaption - Improves stability and range of motion. Shoulder External Rotation from Side Lying - Targets rotator cuff muscles. Shoulder Protraction - Enhances shoulder blade function. Shoulder Extension - Strengthens posterior shoulder muscles
Study: NCT06594055

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring
Description: Continuous glucose monitoring is a wearable device that continuously collects glucose data from interstitial fluid.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring
Description: Continuous glucose monitoring is a wearable device that continuously collects glucose data from interstitial fluid.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Self-monitoring blood glucose
Description: The control group used self-monitoring blood glucose (SMBG) for two weeks with a manual food diary, followed by diet education. They then repeated SMBG with a food diary three months later, with a final follow-up at the 6-month mark.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI food camera
Description: The AI food camera automatically detects the contents and nutritional information of foods.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI food camera
Description: The AI food camera automatically detects the contents and nutritional information of foods.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Food diary
Description: A food diary is a record in which the user manually writes down the consumed foods and their amounts.
Study: NCT06596850

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wheelchair Skills Training Program
Description: Participants will receive 5, 45-minute weekly WC skills training sessions that will take place in the community, in and around the participants home. Each session will be customized to the participant's' goals and based on the learner's impairments (i.e., weakness, spasticity, movement disorders \[e.g. ataxia, tremor\], contractures, cognition). The WSTP sessions will begin with a 5-minute review of goals/progress, followed by a 10-minute warm-up (wheeling activities, random practice of previously leaned skills); 20 minutes of attempting new skills (training on each skill will be carried to next session until the skills are learned or until the trainer and participant mutually agree that training should be abandoned; the trainer will periodically ask the participant to practice newly learned skills to incorporate variability of practice); 10 minute cool-down, during which the participant will practice skills in a self-controlled environment.
Study: NCT06590272

Intervention type: DEVICE
Intervention: TECNIS PCB00 intraocular lens
Description: In this study, we select TECNIS PCB00 IOL for inserting in the eyes during the cataract surgery

Intervention type: DEVICE
Intervention: HumanOptics Diff-Aay intraocular lens
Description: In this study, we select HumanOptics Diff-Aay IOL for inserting in the eyes during the cataract surgery

Intervention type: DEVICE
Intervention: TECNIS Symfony ZXR00 intraocular len
Description: In this study, we select TECNIS Symfony ZXR00 IOL for inserting in the eyes during the cataract surgery

Intervention type: DEVICE
Intervention: ZEISS AT LISA tri 839MP intraocular len
Description: In this study, we select ZEISS AT LISA tri 839MP IOL for inserting in the eyes during the cataract surgery
Study: NCT06592560

Intervention type: DEVICE
Intervention: ELISA
Description: Specific test: Assay of asprosin marker will be measured by enzyme-linked immunosorbent assay ( ELISA).

Intervention type: DEVICE
Intervention: ELISA
Description: Specific test: Assay of asprosin marker will be measured by enzyme-linked immunosorbent assay ( ELISA).

Intervention type: DEVICE
Intervention: ELISA
Description: Specific test: Assay of asprosin marker will be measured by enzyme-linked immunosorbent assay ( ELISA).
Study: NCT06594276

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Local instillation of antibiotics
Description: Systemic antibiotics are usually used with needle aspiration of breast abscess. However local instillation of antibiotics will be an in intervention in this study.
Study: NCT06596122

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D (Cholecalciferol )
Description: In conjunction with the AC-T chemotherapy protocol, individuals in the intervention group who have a vitamin D deficiency will receive an oral loading dose of 50,000 IU weekly for eight weeks. Subsequently, they will be given 100,000 IU monthly until the completion of their chemotherapy treatment.
Study: NCT06585839

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital coaching solution to improve childbirth experience
Description: Intervention provides coaching to improve the childbirth experience and offers comprehensive perinatal mental health support to pregnant and postpartum women. It features emotion tracking and exercise customization functionality, along with an avatar-based platform. The app includes digital psychotherapy exercises and psychoeducation. These core elements are complemented by exercises in mindfulness, relaxation, and self-soothing.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Application for the control group
Description: Application for the control group including surveys.
Study: NCT06586619

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tai chi/qigong intervention group
Description: The intervention is a tai chi/qigong intervention for older people living with HIV. This behavioral group-based intervention will be delivered through Zoom twice a week for 12 weeks. Each class lasts 45-60 minutes. Tai chi/qigong is a slow low impact meditative movement.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Education group
Description: Participants will be assigned to a health and wellness education group for older people living with HIV. This group will be delivered through Zoom twice a week for 12 weeks, and each class will last 45-60 minutes. Each group will learn about and discuss a health and wellness topic.
Study: NCT06601777

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immediate application of the Smart Homespital system
Description: The Smart Homespital system can be applied for the first 3 months (12 weeks), and then the primary and secondary variables will be evaluated at 3, 6, 9months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Delayed application of the Smart Homespital system after 3 months
Description: The waiting list-control group will receive general medical services for the first 3 months and will receive a Smart Homespital system for 3-6 months. Primary and secondary variables will be monitored between 3, 6, and 9 months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.
Study: NCT06593184

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Trans-spinal magnetic stimulation
Description: Trans-spinal magnetic stimulation activate affertent spinal roots and increase cortical excitability.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Comparator
Description: Masking for trans-spinal magnetic stimulation. The sound of stimulation persists even though no magnetic pulses are being delivered
Study: NCT06591676

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dysfunctional Attitude Scale (DAS)
Description: Dysfunctional Attitude Scale (DAS) is a self-report scale designed to measure the presence and intensity of dysfunctional attitudes. It is widely used to assess impaired cognitive patterns associated with depression and other mental health conditions. Initially developed in English, its usefulness can be extended by translating and culturally adapting it into Urdu language.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dysfunctional Attitude Scale (DAS)
Description: Dysfunctional Attitude Scale (DAS) is a self-report scale designed to measure the presence and intensity of dysfunctional attitudes. It is widely used to assess impaired cognitive patterns associated with depression and other mental health conditions. Initially developed in English, its usefulness can be extended by translating and culturally adapting it into Urdu language.
Study: NCT06588439

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive-motor training
Description: Cognitive-motor training is that cognitive tasks incorporated into motor tasks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy
Description: Conventional physiotherapy includes stretching, ROM exercise, strengthening exercise, and eye-hand coordination.
Study: NCT06595316

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise intervention group
Description: Exercise will consist of two supervised sessions per week. Starting with vital signs monitoring (blood pressure, temperature, blood oxygen levels, heart rate).~The aerobic component consists of a 5-minute warm-up, followed by 3 bouts of 4-minute cycling at an intensity of 60-65% HRR, with 2-minute active recovery periods in between and a 5-minute cool down. The goal is to increase up to an intensity of around 80%-85% HRR by weeks 16 to 18. Intensity will be monitored with The Borg Rating Scale of Perceived Exertion (RPE). The resistance component will consist of upper body and lower body exercises (door frame rows, wall push-ups, glute bridges, triceps lifts and squat to calf rise) starting on week one with a set of 12 repetitions of each exercise, with 2-minute recovery in between exercises aiming to increase the number of sets and reducing the number of repetitions.
Study: NCT06586424

Intervention type: DIAGNOSTIC_TEST
Intervention: Anion gap
Description: Patient was taken blood examination before PPCI
Study: NCT06590506

Intervention type: DEVICE
Intervention: Wearable
Description: Continuous monitoring thought data recorded with wearable (Vivosmart Garmin bracelet)

Intervention type: DEVICE
Intervention: Wearable
Description: Continuous monitoring thought data recorded with wearable (Vivosmart Garmin bracelet)

Intervention type: DEVICE
Intervention: Wearable
Description: Continuous monitoring thought data recorded with wearable (Vivosmart Garmin bracelet)
Study: NCT06603142

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Febuxostat 20MG Tablets
Description: Febuxostat 20MG Tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Febuxostat 20MG Placebo
Description: Febuxostat 20MG Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Febuxostat 20MG Placebo
Description: Febuxostat 20MG Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AR882 25MG
Description: AR882 25 MG Capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AR882 25MG
Description: AR882 25 MG Capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AR882 12.5MG
Description: AR882 12.5 MG Capsules

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AR882 25MG Placebo
Description: AR882 25MG Placebo

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AR882 12.5MG Placebo
Description: AR882 12.5MG Placebo

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Febuxostat 40MG Tablets
Description: Febuxostat 40MG Tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Febuxostat 40MG Placebo
Description: Febuxostat 40MG Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Febuxostat 40MG Placebo
Description: Febuxostat 40MG Placebo
Study: NCT06598501

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: an open arm study of 10 gambling disorder subjects will be conducted to determine the efficacy and feasibility of a multimodalistic therapy of rTMS and Cognitive Behavioral Therapy (CBT) for gambling disorder in Indonesia.
Study: NCT06586801

Intervention type: OTHER
Intervention: Patient-reported outcome
Description: Patient-reported outcome data will be collected using the following instruments:EORTC QLQ-C30, EORTC QLQ-LC13, selected items from the PRO-CTCAE, EORTC-IL46.~The first collection of the information in questionnaires (EORTC QLQ-C30, EORTC QLQ-LC13, PRO-CTCAE \[select items\]), which defined as baseline- PROs, will be completed at Cycle 1, Day 1±7days prior to administration of study drug; then the rest times of collection will be completed at every two treatment cycle prior to administration of study drug (i.e., on Cycle 3, Day 1±7days; Cycle 5, Day 1±7days; Cycle 7, Day 1±7days; Cycle 9, Day 1±7days; Cycle 11, Day 1±7days; Cycle 13, Day 1±7days) . EORTC-IL46 will be completed at Cycle 3, Day 1±7days (baseline) prior to administration of study drug; then at every other study treatment cycle prior to administration of study drug (i.e., on Cycle 5, Day 1±7days; Cycle 7, Day 1±7days; Cycle 9, Day 1±7days; Cycle 11, Day 1±7days; Cycle 13, Day 1±7days)

Intervention type: OTHER
Intervention: Patient-reported outcome
Description: Patient-reported outcome data will be collected using the following instruments:EORTC QLQ-C30, EORTC QLQ-LC13, selected items from the PRO-CTCAE, EORTC-IL46.~The first collection of the information in questionnaires (EORTC QLQ-C30, EORTC QLQ-LC13, PRO-CTCAE \[select items\]), which defined as baseline- PROs, will be completed at Cycle 1, Day 1±7days prior to administration of study drug; then the rest times of collection will be completed at every two treatment cycle prior to administration of study drug (i.e., on Cycle 3, Day 1±7days; Cycle 5, Day 1±7days; Cycle 7, Day 1±7days; Cycle 9, Day 1±7days; Cycle 11, Day 1±7days; Cycle 13, Day 1±7days) . EORTC-IL46 will be completed at Cycle 3, Day 1±7days (baseline) prior to administration of study drug; then at every other study treatment cycle prior to administration of study drug (i.e., on Cycle 5, Day 1±7days; Cycle 7, Day 1±7days; Cycle 9, Day 1±7days; Cycle 11, Day 1±7days; Cycle 13, Day 1±7days)

Intervention type: OTHER
Intervention: Patient-reported outcome
Description: Patient-reported outcome data will be collected using the following instruments:EORTC QLQ-C30, EORTC QLQ-LC13, selected items from the PRO-CTCAE, EORTC-IL46.~The first collection of the information in questionnaires (EORTC QLQ-C30, EORTC QLQ-LC13, PRO-CTCAE \[select items\]), which defined as baseline- PROs, will be completed at Cycle 1, Day 1±7days prior to administration of study drug; then the rest times of collection will be completed at every two treatment cycle prior to administration of study drug (i.e., on Cycle 3, Day 1±7days; Cycle 5, Day 1±7days; Cycle 7, Day 1±7days; Cycle 9, Day 1±7days; Cycle 11, Day 1±7days; Cycle 13, Day 1±7days) . EORTC-IL46 will be completed at Cycle 3, Day 1±7days (baseline) prior to administration of study drug; then at every other study treatment cycle prior to administration of study drug (i.e., on Cycle 5, Day 1±7days; Cycle 7, Day 1±7days; Cycle 9, Day 1±7days; Cycle 11, Day 1±7days; Cycle 13, Day 1±7days)
Study: NCT06590701

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early dart throwing motion-mobilization
Description: We compare two different mobilisations in the rehabilitation of patients following scapholunate ligament reconstruction

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Early dart throwing motion-mobilization
Description: We compare two different mobilisations in the rehabilitation of patients following scapholunate ligament reconstruction
Study: NCT06603610

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intensive geriatric service worker model of care
Description: Participants in the intervention group will receive care from an intensive geriatric service worker (IGSW), who will help the participant:~(i) Coordinate community resources and actively support participants' instrumental activities of daily living (IADLs) (e.g., linking participants with Meals-on-Wheels, taking participants to appointments) (ii) Advocate for support from home care for completing activities of daily living (ADLs) (iii) Implement patients' prioritized treatment recommendations made by healthcare professionals (e.g., supporting patients to purchase and install home safety equipment because this aligns with their values and preferences).

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Information brochure and telephone follow-up support
Description: Participants will be e-mailed or mailed a booklet containing information about locally available resources including (1) meal preparation, (2) grocery delivery, (3) housekeeping, (4) pharmacies that deliver medications, (5) home care, and (6) Wheel-Trans. Participants will receive a scripted phone call from the study research coordinator one and three months after study enrolment to see if they have questions about the booklet material.
Study: NCT06589609

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FluBHPVE6E7
Description: Intratumoral administration for first dose followed by intramuscular administration for subsequent doses at recommended dose level and determined schedule.
Study: NCT06604572

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Transabdominal preperitoneal approach
Description: The enrolled patients underwent either open tension-free hernia repair or Transabdominal preperitoneal approach

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transabdominal preperitoneal approach
Description: The enrolled patients underwent either open tension-free hernia repair or Transabdominal preperitoneal approach
Study: NCT06591624

Intervention type: OTHER
Intervention: Prolonged Mechanical Ventilation
Description: The neurosurgical patients who could extubated within 24 h after surgery

Intervention type: OTHER
Intervention: remain intubation after surgery
Description: could not extubated after surgery and prolong mechanical ventilation for 48 hours